Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Izmir Institute of Technology |
| Country | Turkey |
| Start Date | Jan 01, 2023 |
| End Date | Dec 31, 2027 |
| Duration | 1,825 days |
| Number of Grantees | 29 |
| Roles | Associated Partner; Coordinator |
| Data Source | European Commission |
| Grant ID | 101081373 |
Spinning discoveries out of research institutions requires expertise and ecosystem that is hard to bring together in the academic environment.
One of the main challenges is the lack of qualified personnel having multidisciplinary technical skills endowed with transferrable skills.
Biomedical Technologies and Innovation (BIOTIN) doctoral programme features an international, interdisciplinary and intersectoral approach to provide 10 doctoral candidates (DCs) a unique blend of research training skills in the convergence of life sciences, engineering, and computational & data science, and entrepreneurship skills, with the aim of advancing innovation in biomedical research and education.
The BIOTIN programme will address the challenges in three intertwined themes of biomedical research: drug discovery and development, diagnosis, tissue engineering and regeneration, by leveraging latest developments in data science and machine learning.
BIOTIN is presented and coordinated by Izmir Institute of Technology (IZTECH) in collaboration with two implementing partners: Bogazici University (BOUN) and Izmir Biomedicine and Genome Center (IBG).
A total of 22 associated partner organisations including 11 academic and 11 non-academic organisations will contribute to the programme.
BIOTIN fellows will benefit from a highly-qualified interdisciplinary supervisory team, secondment-and short-visits to network partners in Europe and beyond including prominent universities, NGO (Istanbul Health Industry Cluster), large enterprises (e.g.
Siemenes Healthineers and Amgen) and start-ups, alongside the opportunity to develop and practice entrepreneurship skills in leading technology development zones of Turkey.The consortium will build a group of researchers with a valuable and rare blend of academic skills and industry readiness, who in return can fulfil regional, national and international human resources needs in biomedical research far beyond the funding period.
Universidade Do Minho; Friedrich-Alexander-Universitaet Erlangen-Nuernberg; Rs Arastirma Egitim Danismanlik Ilac Sanayi Ticaret Anonim Sirketi; Uniwersytet Warszawski; Cleveland State University; Universiteit Antwerpen; Dokuz Eylul Universitesi; Villanova University; Izmir Ekonomi Universitesi; Solaris Genomics Arge Ve Saglik Teknolojileri Anonim Sirketi; Stichting Radboud Universiteit; Temple University of the Commonwealth System of Higher Education; Turkiye Bilimsel Ve Teknolojik Arastirma Kurumu; Boise State University; Amgen Ilac Tic Ltd Sti; Izmir Institute of Technology; Izmir Teknoloji Gelistirme Bolgesi A.S; University of Pittsburgh; Letgen Biyoteknoloji Ltd.Sti; Universita Della Svizzera Italiana; Universitat Politecnica de Catalunya; University of Warwick; Fujifilm Sonosite Bv; Centre National de la Recherche Scientifique CNRS; Atmosfer Tto; Xnk Therapeutics Ab; Siemens Healthcare Saglik A.S.; Barcelona Supercomputing Center Centro Nacional de Supercomputacion; Istanbul Health Industry Cluster
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant